EXECUTIVE LEADERSHIP SERIES

ASHTON TWEED'S EXECUTIVE INTERVIEWS

October 24, 2023

Executive Leadership Series: How Embracing an Unexpected New Opportunity Renewed An Executive’s Drive to Succeed

Hema Tallman Senior Vice President and Global Head BioLife Plasma Services, Takeda For Hema Tallman, leading BioLife Plasma Services, part of global biopharmaceutical company Takeda, has […]
October 6, 2023

Executive Leadership Series: How a CEO Left Semi-Retirement to Lead a Biotech Research Company’s Transition to Product Development

Robert Bitterman Executive Chair and CEO Phio Pharmaceuticals Corp. When Ashton Tweed last talked with Robert Bitterman in 2018, he was helming the dermatology company he […]
November 9, 2020

CEO Leadership Series: A Biopharma Executive’s Next Act in Developing Life-Changing Treatments

When Susan Dillon co-founded Aro Biotherapeutics in 2018, she had already led teams of researchers at Johnson & Johnson to develop revolutionary drugs for autoimmune diseases—Remicade®, Simponi, Stelara® and Tremfya®.
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406